The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells

Gynecologic Oncology

Volumn 81, Issue 2, 2001, Pages 254-262

  Yovel, Galit ^a   Shakhar, Keren ^a   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Menstrual cycle; NK activity; Oral contraceptive; Sex

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYPROTERONE ACETATE; DESOGESTREL; ETHINYLESTRADIOL; GESTODENE; LEVONORGESTREL; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; ASSAY; CELL ACTIVITY; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; LYMPHOCYTE; MALE; MENSTRUAL CYCLE; NATURAL KILLER CELL; NORMAL HUMAN; ORAL CONTRACEPTION; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE;

EID: 0035024521     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6153     Document Type: Article

References (50)

1. Interactions between the gonadal steroids and the immune system
2. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis
3. Variation in natural killer activity in peripheral blood during the menstrual cycle
4. Psychobiological factors related to human natural killer cell activity and hormonal modulation of NK cells in vitro
5. Biology and clinical relevance of human natural killer cells
6. Natural killer cells: Their roles in defenses against disease
7. NK cell activity and estrogen hormone levels during normal human pregnancy
8. Changes in natural killer cell activity in normal pregnant and postpartum women: Increases in the first trimester and postpartum period and decrease in late pregnancy
9. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy
10. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment
11. Effect of sex hormones on NK and ADCC activity of mice
12. Lymphocyte subsets in women on low dose oral contraceptives
13. Effect of low-dose oral contraceptives on natural killer cell activity
14. Natural killer cell activity is reduced in association with oral contraceptive use
15. Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease
16. Comparison of natural killer activity during the first and second halves of the menstrual cycle in women
17. Enumerative immune changes following acute stress: Effect of the menstrual cycle
18. Natural killer cell activity: Age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential
19. Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: Possible role of oestradiol and natural killer cells
20. Timing of adrenergic stimulation within the estrous cycle affects resistance to metastasis and levels of NK cell activity: Possible clinical implications
21. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers
22. Effect of smoking on human natural killer cell activity
23. NK and K cell activity of human blood: Differences according to sex, age, and disease
24. A modified short-term cytotoxicity test: Assessment of natural cell mediated cytotoxicity in whole blood
25. Quantitation of a whole blood assay for human natural killer cell activity
26. Properties and usefulness of the original K-562 human myelogenous leukemia cell line
27. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
28. Lytic units reconsidered: Pitfalls in calculation and usage
29. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats
30. Hormonal modulation of human natural killer cell activity in vitro
31. Age- and sex-dependent changes in natural killer cell activity
32. Oestrogen as an inhibitor of human NK cell cytolysis
33. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes
34. Natural killer cells in normal pregnancy: Analysis using monoclonal antibodies and single-cell cytotoxicity assays
35. Cytotoxic activity and phenotypic analysis of natural killer cells in early normal human pregnancy
36. Natural killer cell activity during pregnancy
37. Modulation of lymphokine-activated killer cell-mediated cytotoxicity by estradiol and tamoxifen
38. Catecholamine-induced leukocytosis: Early observations, current research, and future directions
39. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells
40. Beta 2-adrenergic stimulation causes detachment of natural killer cells from cultured endothelium
41. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium
42. Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle
43. Beta-adrenergic receptors in human leukocyte subpopulations
44. Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity
45. Beta 2- and alpha 2-adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiological variations of sex steroids
46. Cardiovascular, endocrine, and receptor measures as related to sex and menstrual cycle phase
47. The effects of the menstrual cycle, race, and gender on adrenergic receptors and agonists
48. Premenstrual syndromes
49. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity
50. Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells